Maximilian Kleinert1,2, Timo D Müller3,4,5. 1. Institute for Diabetes and Obesity, Helmholtz Diabetes Center, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany. 2. Section of Molecular Physiology, Department of Nutrition, Exercise and Sports, Faculty of Science, University of Copenhagen, Copenhagen, Denmark. 3. Institute for Diabetes and Obesity, Helmholtz Diabetes Center, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany. timo.mueller@helmholtz-muenchen.de. 4. German Center for Diabetes Research (DZD), Neuherberg, Germany. timo.mueller@helmholtz-muenchen.de. 5. Department of Pharmacology and Experimental Therapy, Institute of Experimental and Clinical Pharmacology and Toxicology, Eberhard Karls University Hospitals and Clinics, Tübingen, Germany. timo.mueller@helmholtz-muenchen.de.
Authors: Maximilian Kleinert; Kirstine N Bojsen-Møller; Nils B Jørgensen; Maria S Svane; Christoffer Martinussen; Bente Kiens; Jørgen F P Wojtaszewski; Sten Madsbad; Erik A Richter; Christoffer Clemmensen Journal: Am J Physiol Endocrinol Metab Date: 2019-02-05 Impact factor: 4.310
Authors: Vicky Wang-Wei Tsai; Laurence Macia; Christine Feinle-Bisset; Rakesh Manandhar; Arne Astrup; Anne Raben; Janne Kunchel Lorenzen; Peter T Schmidt; Fredrik Wiklund; Nancy L Pedersen; Lesley Campbell; Adamandia Kriketos; Aimin Xu; Zhou Pengcheng; Weiping Jia; Paul M G Curmi; Christopher N Angstmann; Ka Ki Michelle Lee-Ng; Hong Ping Zhang; Christopher P Marquis; Yasmin Husaini; Christoph Beglinger; Shu Lin; Herbert Herzog; David A Brown; Amanda Sainsbury; Samuel N Breit Journal: PLoS One Date: 2015-07-24 Impact factor: 3.240
Authors: Maximilian Kleinert; Christoffer Clemmensen; Kim A Sjøberg; Christian Strini Carl; Jacob Fuglsbjerg Jeppesen; Jørgen F P Wojtaszewski; Bente Kiens; Erik A Richter Journal: Mol Metab Date: 2018-01-17 Impact factor: 7.422
Authors: Henriette Frikke-Schmidt; Karin Hultman; Joseph W Galaske; Sebastian B Jørgensen; Martin G Myers; Randy J Seeley Journal: Mol Metab Date: 2019-01-14 Impact factor: 7.422